BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11310966)

  • 41. [Property of liposomal fusion induced by acid-sensitive polymer].
    Wang RT; Chen T; Wang Z; Hui MQ; Fu JG
    Yao Xue Xue Bao; 2008 Sep; 43(9):951-5. PubMed ID: 19048789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics.
    Garg M; Asthana A; Agashe HB; Agrawal GP; Jain NK
    J Pharm Pharmacol; 2006 May; 58(5):605-16. PubMed ID: 16640829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liposomal nanomedicines.
    Fenske DB; Cullis PR
    Expert Opin Drug Deliv; 2008 Jan; 5(1):25-44. PubMed ID: 18095927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liposomes: a novel topical delivery system for pharmaceutical and cosmetic applications.
    Weiner N; Lieb L; Niemiec S; Ramachandran C; Hu Z; Egbaria K
    J Drug Target; 1994; 2(5):405-10. PubMed ID: 7704485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liposome-based delivery system for vaccine candidates: constructing an effective formulation.
    Giddam AK; Zaman M; Skwarczynski M; Toth I
    Nanomedicine (Lond); 2012 Dec; 7(12):1877-93. PubMed ID: 23249332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liposomes: a drug carrier system for topical treatment in dermatology.
    Schmid MH; Korting HC
    Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):97-118. PubMed ID: 7600589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liposomal cyclosporine. Characterization of drug incorporation and interbilayer exchange.
    Ouyang C; Choice E; Holland J; Meloche M; Madden TD
    Transplantation; 1995 Nov; 60(9):999-1006. PubMed ID: 7491708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Methods to increase the encapsulation efficiency for liposomal drugs].
    Kaszás N; Budai M; Budai L; Gróf P; Zimmer A; Klebovich I
    Acta Pharm Hung; 2008; 78(2):69-74. PubMed ID: 18807386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Trends in the development of research in the field of liposomes (review of patent literature)].
    Nesytova NIu; Paleva NS; Il'ina EV; Shenk P; Bendas F; Nun P
    Vestn Akad Med Nauk SSSR; 1990; (6):8-19. PubMed ID: 2220043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liposomal Delivery Systems: Design Optimization and Current Applications.
    Abu Lila AS; Ishida T
    Biol Pharm Bull; 2017; 40(1):1-10. PubMed ID: 28049940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liposomal drug delivery systems: an update review.
    Samad A; Sultana Y; Aqil M
    Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization.
    Sihorkar V; Vyas SP
    J Pharm Pharm Sci; 2001; 4(2):138-58. PubMed ID: 11466172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers.
    Ranade VV
    J Clin Pharmacol; 1989 Aug; 29(8):685-94. PubMed ID: 2674208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Drug delivery system for infectious diseases].
    Maesaki S; Kohno S
    Nihon Rinsho; 1998 Mar; 56(3):752-61. PubMed ID: 9549369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liposomal forms of anticancer agents beyond anthracyclines: present and future perspectives.
    Papachristos A; Pippa N; Ioannidis K; Sivolapenko G; Demetzos C
    J Liposome Res; 2015; 25(2):166-73. PubMed ID: 25148295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fate and behavior of liposomes in vivo: a review of controlling factors.
    Senior JH
    Crit Rev Ther Drug Carrier Syst; 1987; 3(2):123-93. PubMed ID: 3542245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liposomes in drug delivery: a patent review (2007 - present).
    Arias JL
    Expert Opin Ther Pat; 2013 Nov; 23(11):1399-414. PubMed ID: 23957267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lyophilized preliposomal formulation of the non-cross-resistant anthracycline annamycin: effect of surfactant on liposome formation, stability and size.
    Zou Y; Priebe W; Perez-Soler R
    Cancer Chemother Pharmacol; 1996; 39(1-2):103-8. PubMed ID: 8995506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipid-based carriers: manufacturing and applications for pulmonary route.
    Jaafar-Maalej C; Elaissari A; Fessi H
    Expert Opin Drug Deliv; 2012 Sep; 9(9):1111-27. PubMed ID: 22724618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A review of glycosylated carriers for drug delivery.
    Jain K; Kesharwani P; Gupta U; Jain NK
    Biomaterials; 2012 Jun; 33(16):4166-86. PubMed ID: 22398205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.